Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PrimCHIX:PRME 74 EV-to-OCF is 7.21 as of Jul. 27, 2026, which is 51% below its 10-year median of 14.62. GuruFocus rates CHIX:PRME with a GF Score™ of 74/100 and a GF Value™ of €6.75. The stock has 5 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Prim ranks better than 50.94% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Prim's Enterprise Value is €219.5 Mil.
Prim's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €30.5 Mil. Therefore, Prim's EV-to-OCF for today is 7.21.
The historical rank and industry rank for Prim's EV-to-OCF or its related term are showing as below:
CHIX:PRMe'
s EV-to-OCF Range Over the Past 10 Years
Min: -334.09 Med: 14.62 Max: 1068.51
Current: 7.21
During the past 13 years, the highest EV-to-OCF of Prim was 1068.51. The lowest was -334.09. And the median was 14.62.
CHIX:PRMe's EV-to-OCF is ranked better than 50.94% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.75
vs CHIX:PRMe: 7.21
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-27), Prim's stock price is €10.90.
Prim's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.980. Therefore, Prim's PE Ratio (TTM) for today is 11.12.
Prim (CHIX:PRMe) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Prim's share price for today is €10.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Prim's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.980.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Prim EV-to-OCF Related Terms
Prim EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Prim's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:PRME vs ISRG, BDX, MDLN: EV-to-OCF Comparison
For the Medical Instruments & Supplies subindustry, Prim's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prim EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prim's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Prim's EV-to-OCF falls into.
Prim's current Enterprise Value is €219.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Prim's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €30.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prim (CHIX:PRME) has a EV-to-OCF of 7.21 as of Jul. 27, 2026. This is 51% below median its historical median of 14.62. According to the industry distribution chart, Prim ranks #418 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 49.1%.
Is Prim's EV-to-OCF too high?
Prim's current EV-to-OCF of 7.21 is 51% below median its 10-year median of 14.62. The Medical Devices & Instruments industry median EV-to-OCF is 7.75. Prim's value of 7.21 is 7% below this industry median. Based on the distribution chart, Prim ranks #418 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Prim has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Prim's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prim ranks #418 out of 852 companies for EV-to-OCF. This puts Prim in the upper half of its industry. The industry median EV-to-OCF is 7.75. Prim's value of 7.21 is 7% below this benchmark. While the company's 10-year median is 14.62 vs. the industry median of 7.75, Prim has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.75, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prim's current EV-to-OCF of 7.21 is 7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prim's current EV-to-OCF is 7.21, which is 51% below median its own 10-year median of 14.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prim stock overvalued right now?
Prim (CHIX:PRME) has a current EV-to-OCF of 7.21. The stock's GF Value™ is €6.75, compared to a current price of €10.90 — trading 61.5% above its estimated fair value. The current EV-to-OCF is 7.21, which is 51% below median its 10-year median of 14.62 and 7% below the Medical Devices & Instruments industry median of 7.75. Prim's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Prim (CHIX:PRME), the current EV-to-OCF is 7.21 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prim (CHIX:PRME) Overvalued in 2026?
Based on GuruFocus' analysis, Prim stock appears to be overvalued.
The current stock price of €10.90 is trading 61.5% above its estimated GF Value™ of €6.75.
Key valuation signals for CHIX:PRME:
EV-to-OCF: 7.21 (51% below median its 10-year median of 14.62)
GF Value™: €6.75 vs. price of €10.90 (61.5% above fair value)
Industry Position: 7% below the Medical Devices & Instruments median (#418 of 852)
No single metric tells the full story. See the CHIX:PRME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
74GF Score
Get the complete analysis for CHIX:PRME
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:PRME has been successfully added to your 
